Announcement on Conversion Result of Convertible Bonds and Share Changes
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
View Attachment
Announcement on Conversion Result of Convertible Bonds and Share Changes
Filed with SSE ·
6ix hasn’t read this filing yet.
Sinopep-Allsino Bio Pharmaceutical Co., Ltd. on 6ix
Earlier from Sinopep-Allsino Bio Pharmaceutical
- Announcement on Voluntary Disclosure of Performance Forecast in the First Quarter of 2025
- Indicative Announcement on "Sinopep-Allsino Convertible Bonds" Expected to Meet Redemption Conditions
- Announcement on Voluntary Disclosure of Subsidiary Passing the U.S. FDA On-site Inspection
- Announcement on Preliminary Earnings Estimate for 2024
- Announcement on Voluntary Disclosure of Passing GMP On-site Inspection for Drugs
Later from Sinopep-Allsino Bio Pharmaceutical
- Announcement on Voluntary Disclosure of Strategic Cooperation
- Announcement on Implementing Redemption and Delisting of "Sinopep-Allsino Convertible Bonds"
- The 2nd Indicative Announcement on the Implementation of Redemption and Delisting of "Sinopep-Allsino Convertible Bonds"
- The 3rd Indicative Announcement on the Implementation of Redemption and Delisting of "Sinopep-Allsino Convertible Bonds"
- Special Report on Deposit and Use of Raised Funds in 2024
Follow Sinopep-Allsino Bio Pharmaceutical into a list and get an email when it puts out news.
Follow Sinopep-Allsino Bio Pharmaceutical